Mark Kay
Dennis Farrey Family Professor, Departments of Pediatrics and Genetics; Head, Division of Human Gene Therapy, Stanford University
Mark Kay is listed as Dennis Farrey Family Professor, Departments of Pediatrics and Genetics; Head, Division of Human Gene Therapy, Stanford University. Mark is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Mark. Is this you? Claim this profile.
About
Mark A. Kay is the Dennis Farrey Family Professor in Pediatrics and a Professor of Genetics at Stanford University School of Medicine, where he heads the division of human gene therapy. Professor Kay has made seminal contributions in the fields of nucleic acid therapeutics, genome editing, RNAi therapeutics, and non-coding RNA biology. His work spans basic research through clinical trial research that includes the first systemic delivery of AAV into humans. He has published 300 research articles. As a founder of the American Society of Gene and Cell Therapy, Dr. Kay served as the society’s 9th president in 2006, and was the recipient of its Outstanding Achievement Award in 2013. He is currently a deputy editor of Human Gene Therapy and serves on the editorial boards of other peer-reviewed publications. He was elected to the National Academy of Inventors in 2020. Professor Kay has served as a graduate student/post-doctoral/mentor to many current members of ASGCT and ESGCT who are active
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Panel discussion: What is the data telling us about the clinical pathway to safe and efficacious in vivo gene therapy products? Speaker · 19 January 2027
- Session 1: How are key gene delivery platforms stacking up both in vivo and ex vivo to address concerns around safety, immunogenicity, durability, efficacy, and redosing potential? Speaker · 19 January 2027
- Panel discussion Speaker · 20 January 2027
- Session 5: Viral Vectors - Innovation in AAV: Building the next generation of safe, scalable and affordable vector platforms Speaker · 20 January 2027
- Spotlight: Beyond the Membrane: Mechanistic insights into differential transduction by AAV capsids Speaker · 20 January 2027
Spoke alongside
People who have shared a session with Mark at events on B2DB.
- Kate Excoffon American Society for Gene and Cell Therapy · American Society of Gene & Cell Therapy 2 shared sessions
- Katy Barglow CTO · 4D Molecular Therapeutics 2 shared sessions
- Mercedes Segura Gally VP Process Development · Editas Medicine 2 shared sessions
- Romuald Corbau CSO · Capsida Biotherapeutics 2 shared sessions